420 with CNW — DEA-Approved Cannabis Cultivator Debuts on

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
329
420 with CNW — DEA-Approved Cannabis Cultivator Debuts on NASDAQ

Bright Green Corp., a Florida-based cannabis company, made history last week by being the first “plant-touching” company to list its shares on a major securities exchange within the United States. The company, which boasts of being in possession of conditional approval from the U.S. Drug Enforcement Administration to grow research-grade marijuana, started trading on the NASDAQ exchange under the ticker BGXX on Tuesday last week.

The exchange had earlier set $8 as the reference price for a share of this company, but when trading opened on Tuesday, the stocks started trading at $15.99. In the course of the day, the price climbed up to a maximum price of $36.44 though it eventually ended the day at $25.25. This closing price depicted a 216% increase from the reference price at which a share was set just before trading started.

It should be noted that BGXX was categorized as a direct listing. In such a listing, the current shareholders of a company sell some of their shares, and the company doesn’t receive the proceeds from such a sale of stocks. SEC filings indicate that Bright Green’s shareholders agreed to sell 158.2 million shares.

At the close of the company’s first day of trading, Bright Green had a $4 billion valuation on the basis of the price at which a share closed. This is huge given that Bright Green hasn’t started making sales. The company is constructing a cultivation and processing facility worth $300 million in Grants, New Mexico.

At the moment, the major shareholders in Bright Green are Lynn Stockwell, a director in the company owning 69.6 million shares, and Terry Rafih, also a director who owns a little more than 20 million shares. Edward Robinson, the CEO of the company, currently owns 5 million of the company’s shares while his wife has 605,000 company shares to her name.

Bright Green says it plans to commercialize cannabis products, but only after the U.S. federal government has ended the prohibition of marijuana. This is one of the key positions the company took in order to distinguish itself from other marijuana companies that are operating under state laws. The filings Bright Green made to the Securities and Exchange Commission emphasize this distinction.

For decades, only the University of Mississippi had a facility to grow DEA-approved marijuana for research purposes. That monopoly is being dismantled, and Bright Green is one of the applicants that have been given conditional approval to grow marijuana for research purposes.

The cannabis industry looks forward to the time when domestic companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS) can access the huge amounts of capital available to companies that list on the NASDAQ, NYSE and other securities exchanges in the United States.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer


Cannabis Strategic Ventures, Inc (NUGS) Stock Research Links

NUGS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 208

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 155

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 61

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 309

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 526

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 48

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 809

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 144

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 555

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 105

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading

Top 5 Most Recently Viewed Articles

Batteries Plus Celebrates 31 Years on Franchise 500 List

Updated Category News Views 190

Batteries Plus Secures Spot on Franchise 500 List The world's leading battery retailer, Batteries Plus, has made headlines again by being recognized as one of the top 500 franchises by Entrepreneur Magazine. This remarkable achievement marks the 31st consecutive year that the brand has secured a place on this coveted list. With this year's ranking showcasing a jump of 20...

Continue Reading
Nvidia and Broadcom Lead the Charge in the AI Revolution

Updated Category News Views 263

The Rise of Nvidia and Broadcom in AI Technology The technology landscape is rapidly evolving, primarily driven by advancements in artificial intelligence (AI). Leaders in this space, Nvidia Corp (NASDAQ: NVDA) and Broadcom Inc (NASDAQ: AVGO), are setting the foundation for the future with their innovative silicon solutions. The focus is shifting towards hardware...

Continue Reading
Highlights from the Fusion Commission's New Appointments

Updated Category News Views 407

Exciting Developments in Fusion Energy Leadership The Special Competitive Studies Project (SCSP) is creating buzz in the fusion energy sector with its recent announcement regarding the final two commissioners, Manu Asthana and Dr. Rachel Slaybaugh. This initiative brings together some of the brightest minds in the field, all focused on advancing nuclear technologies and...

Continue Reading
Copenhagen Airports A/S Announces Preliminary Tender Offer Results

Updated Category News Views 96

Overview of the Tender Offer Results Copenhagen Airports A/S is pleased to share significant updates regarding the tender offer presented to its shareholders. The notification received from the Kingdom of Denmark highlights the preliminary outcomes, giving stakeholders vital insights into the ongoing financial strategies of the company. Key Information for Shareholders...

Continue Reading
AMC Networks Inc Faces Legal Scrutiny Amid Financial Losses

Updated Category News Views 195

AMC Networks Inc Faces Legal Scrutiny Amid Financial Challenges AMC Networks Inc, a well-known entity in the entertainment industry, is experiencing turbulent times as allegations of securities fraud surface. Investors are urged to take notice of these developments that might affect their interests. Investigation by Pomerantz LLP Pomerantz LLP, a prominent law firm...

Continue Reading